ARTICLE | Clinical News
CoFactor: Phase III started
July 3, 2006 7:00 AM UTC
ANX started an open-label, U.S. Phase III trial in 1,200 patients. The trial will compare CoFactor to leucovorin. Both compounds will be given in combination with 5-FU and Avastin. Avastin bevacizuma...